Sterling Capital Management’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$951K Sell
24,760
-578
-2% -$22.2K 0.01% 649
2025
Q1
$982K Buy
25,338
+1,789
+8% +$69.3K 0.02% 619
2024
Q4
$796K Buy
23,549
+2,113
+10% +$71.5K 0.01% 705
2024
Q3
$876K Buy
+21,436
New +$876K 0.01% 637
2019
Q3
$377K Hold
7,062
﹤0.01% 782
2019
Q2
$353K Sell
7,062
-188
-3% -$9.4K ﹤0.01% 786
2019
Q1
$379K Sell
7,250
-1,734
-19% -$90.6K ﹤0.01% 767
2018
Q4
$429K Sell
8,984
-825
-8% -$39.4K ﹤0.01% 766
2018
Q3
$493K Sell
9,809
-643
-6% -$32.3K ﹤0.01% 787
2018
Q2
$527K Sell
10,452
-2,796
-21% -$141K ﹤0.01% 753
2018
Q1
$647K Buy
13,248
+1,281
+11% +$62.6K 0.01% 730
2017
Q4
$531K Buy
11,967
+1,919
+19% +$85.2K ﹤0.01% 763
2017
Q3
$510K Buy
10,048
+3,170
+46% +$161K ﹤0.01% 768
2017
Q2
$371K Sell
6,878
-305
-4% -$16.5K ﹤0.01% 806
2017
Q1
$379K Buy
7,183
+25
+0.3% +$1.32K ﹤0.01% 821
2016
Q4
$345K Sell
7,158
-569
-7% -$27.4K ﹤0.01% 826
2016
Q3
$417K Buy
7,727
+272
+4% +$14.7K ﹤0.01% 769
2016
Q2
$404K Buy
7,455
+873
+13% +$47.3K ﹤0.01% 783
2016
Q1
$334K Buy
6,582
+55
+0.8% +$2.79K ﹤0.01% 805
2015
Q4
$329K Sell
6,527
-42
-0.6% -$2.12K ﹤0.01% 849
2015
Q3
$316K Buy
6,569
+331
+5% +$15.9K ﹤0.01% 857
2015
Q2
$325K Buy
6,238
+681
+12% +$35.5K ﹤0.01% 783
2015
Q1
$321K Buy
5,557
+1,640
+42% +$94.7K ﹤0.01% 775
2014
Q4
$209K Buy
+3,917
New +$209K ﹤0.01% 891
2014
Q2
Sell
-5,804
Closed -$387K 895
2014
Q1
$387K Buy
+5,804
New +$387K ﹤0.01% 815